Evolution, risk factors, and prognostic implications of albuminuria in NIDDM

Diabetes Care

Volumn 19, Issue 5, 1996, Pages 486-493

  Niskanen, Leo K ^a,b   Penttilä, Ilkka ^a   Parviainen, Markku ^a   Uusitupa, Matti I J ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIABETES CONTROL; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HUMAN; HYPERINSULINEMIA; HYPERTENSION; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PROGNOSIS; RISK FACTOR; URINARY EXCRETION;

EID: 0029862592     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.19.5.486     Document Type: Article

References (52)

1. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
2. Wang PH, Lau J, Chalmeras TC: Meta-analysis of the effects of intensive blood-glucose control on late complications of type 1 diabetes. Lancet 341:1306-1309, 1993
3. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD: The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy N Engl J Med 329:1456-1462, 1993
4. Viberti GC, Mogensen CE, Groop LC, Pauls JF: Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes and microalbuminuria. JAMA 271:275-279, 1994
5. Mogensen CE: Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes N Engl J Med 310:356-360, 1984
6. Jarrett RJ, Viberti GC, Argyropoulus A, Hill RD, Mahmud U, Murrells TJ: Microalbuminuria predicts mortality in non-insulin-dependent diabetes. Diabetic Med 5:126-134, 1988
7. Schmitz A, Veath M: Microalbuminuria: a major risk factor in non-insulin dependent diabetes: a 10-year follow-up study of 503 patients. Diabetic Med 5-126-134, 1988
8. Mattock MB, Morrish NJ, Viberti G, Keen H, Fitzerald AP, Jackson G: Prospective study of microalbuminuria as predictor of mortality in NIDDM Diabetes 41:736-741, 1992
9. Neil A, Hawkins M, Potok M, Thorogood M, Cohen D, Mann J: A prospective population-based study of microalbuminuria as a predictor of mortality in NIDDM. Diabetes Care 16:996-1003, 1993
10. Damsgaard EM, Froland A, Jorgensen OD, Mogensen CE: Eight to nine year mortality in known non-insulin-dependent diabetics and controls. Kidney Int 41: 731-735, 1991
11. Yudkin JS, Forrest RD, Jackson CA: Microalbuminuria as predictor of vascular disease in non-diabetic subjects: Islington Diabetes Survey Lancet ii:530-533, 1988
12. Damsgaard EM, Froland A, Jorgensen OD, Mogensen CE: Microalbuminuria as predictor of increased mortality in elderly people Br Med J 300:297-300, 1990
13. Kuusisto J, Mykkänen L, Pyörälä K, Laakso M: Hyperinsulinemic microalbuminuria: a new risk indicator for coronary heart disease. Circulation 91:831-837, 1995
14. Niskanen L, Uusitupa M, Sarlund H, Siitonen O, Voutilainen E, Penttilä I, Pyöräla K: Microalburninuna predicts the development of serum lipoprotein abnormalities favouring atherogenesis in newly diagnosed type 2 (non-insulin-dependent) diabetic patients. Diabetologia 33:237-243, 1990
15. Gall M-A, Rossing P, Skott P, Damsbo P, Vaag A, Bech K, Dejgaard A, Lauritzen M, Lauritzen E, Hoigaard P, Beck-Nielsen H, Parving HH: Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients. Diabetologia 34:655-661, 1991
16. Winocour PH, Harland JOE, Millar JP, Laker MF, Alberti KGMM: Microalbuminuria and associated cardiovascular risk factors in the community. Atherosclerosis 93 71-81, 1992
17. Zambon S, Mansato E, Solini A, Sambataro M, Brocco E, Sartore G, Crepaldi G, Nosadini R: Lipoprotein abnormalities in non-insulin-dependent diabetic patients with impaired extrahepatic insulin sensitivity, hypertension, and microalbuminuria. Arterioscler Thromb 14:911-916, 1994
18. Stehouwer CDA, Nauta JJP, Zeldenrust GC, Hackerig WHL, Donker AJM, Den Ottolander GJH: Urinary albumin excretion, cardiovascular disease and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet 340:319-323, 1992
19. Niskanen L, Voutilainen R, Teräsvirta M, Lehtinen J, Teppo A-M, Groop L, Uusitupa M: A prospective study of clinical and metabolic associates of proteinuria in patients with type 2 diabetes mellitus. Diabetic Med 10:543-549, 1993
20. Niskanen L, Laakso M: Insulin resistance is related to albuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus. Metabolism 42:1541-1545, 1993
21. Groop L, Ekstrand A, Forsblom C, Widen E, Groop P-H, Teppo A-M, Eriksson J: Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus Diabetologia 36:642-647, 1993
22. Nosadini R, Solini A, Velussi M, Muollo B, Frigato F, Sambataro M, Cipollina MR, DeRiva F, Brocco E, Crepaldi G. Impaired insulin-induced glucose uptake is hallmark of NIDDM patients who have or will develop hypertension and microalbuminuria. Diabetes 43 491-499, 1994
23. Uusitupa M, Sutonen O, Aro A, Pyöralä K: Prevalence of coronary heart disease, left ventricular failure and hypertension in middle-aged, newly diagnosed type 2 (non-insulin-dependent) diabetic subjects. Diabetologia 28:22-27, 1988
24. Niskanen LK, Uusitupa MI, Sarlund H, Siitonen O, Pyöralä K: Five-year follow-up study on plasma insulin levels in newly diagnosed NIDDM patients and nondiabetic subjects. Diabetes Care 13 41-48, 1990
25. Uusitupa MIJ, Niskanen LK, Sutonen O, Voutilainen E, Pyorälä K: Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia 36:1175-1184, 1993
26. Niskanen L, Karjalainen J, Sutonen O, Uusitupa M: Metabolic evolution of type 2 diabetes: 10-year follow-up. J Intern Med 236:263-270, 1994
27. World Health Organization: WHO Expert Committee on Diabetes Mellitus. Second Report. Geneva, World Health Org., 1980 (Tech Rep. Ser., no. 646)
28. Pentulä IM, Voutilainen E, Laitinen P, Juutilainen P: Comparison of different analytical and precipitation methods for the direct estimation of serum high-density lipoprotein cholesterol Scand J Clin Lab Invest 41:353-360, 1981
29. Laakso M, Reunanen A, Klaukka T, Aromaa A, Maatela J, Pyörälä K: Changes in the prevalence and incidence of diabetes mellitus in Finnish adults, 1970-1987. Am J Epidemiol 133:850-857, 1991
30. Erman A, Rabinov M, Rosenfeld J: Albumin determinations in frozen urines: underestimated results. Clin Chim Acta 174: 255-262, 1988
31. Collins ACG, Sethi M, MacDonald FA, Brown D, Viberti GC: Storage temperature and differing methods of sample preparation in the measurement of urinary albumin Diabetologia 36:993-997, 1993
32. Partanen J, Niskanen L, Lehtinen J, Siitonen O, Mervaala E, Uusitupa M: Natural history of peripheral neuropathy in NIDDM. N Engl J Med 333-89-94, 1995
33. Schmitz A, Vaeth M, Mogensen CE: Systolic blood pressure relates to the rate of progression of albuminuria in NIDDM. Diabetologia 37:1251-1258, 1994
34. Pettitt DJ, Lisse JR, Knowler WC, Bennett PH: Development of retinopathy and proteinuria in relation to plasma glucose concentrations in Pima Indians. Lancet ii: 1050-1052, 1980
35. Fabre J, Balant LP, Dayer PG, Fox HM, Verner A: The kidney in maturity onset diabetes mellitus, a clinical study of 510 patients. Kidney Int 21:730-738, 198
36. Ballard DJ, Humphrey LL, Melton J III, Frohnert PP, Chu C, O'Fallon WM, Palumbo PJ: Epidemiology of persistent proteinuria in type II diabetes mellitus: population-based study in Rochester, Minnesota. Diabetes 37:405-412, 1988
37. Schmitz A, Hansen HH, Christensen T. Kidney function in newly diagnosed type 2 (non-insulin-dependent) diabetic patients, before and during treatment. Diabetologia 32:434-439, 1989
38. Jerums G, Cooper ME, Seeman E, Murray RML, McNeil JJ: Spectrum of proteinuria in type I and type II diabetes. Diabetes Care 10:419-427, 1987
39. Ravid M, Savin H, Lang R, Jutrin I, Shoshana L, Lishner M: Proteinuria, renal impairment, metabolic control and blood pressure in type 2 diabetes mellitus. Arch Intern Med 152:1225-1229, 1992
40. Klein R, Klein BEK, Linton KLP, Moss SE: Microalbuminuria in a population-based study of diabetes. Arch Intern Med 152: 153-158, 1992
41. Microalbuminuria Collaborative Study Group: Risk factors for development of microalbuminuria in insulin dependent diabetic patients a cohort study. Br Med J 306:1235-1239, 1993
42. Powrie JK, Watts GF, Ingham JN, Taub NA, Talmud PJ, Shaw KM: Role of glycaemic control in development of microalbuminuria in patients with insulin dependent diabetes. Br Med J 309:1608-1612, 1994
43. Gerber LM, Shmukler C, Alderman MH: Differences in urinary albumin excretion rate between normotensive and hypertensive, white and nonwhite subjects. Arch Intern Med 152:373-377, 1992
44. Winocour PH, Harland JOE, Millar JP, Laker MF, Alberti KGMM: Microalbuminuria and associated cardiovascular risk factors in the community. Atherosclerosis 93: 71-81, 1992
45. Mogensen CE: Systemic blood pressure and glomerular leakage with particular reference to diabetes and hypertension. J Intern Med 235:297-316, 1994
46. Ravid M, Savin H, Jutrin I, Bental T, Katz B, Lishner M: Long-term stabilizing effect of angiotensin-converting enzyme on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Intern Med 118:577-581, 1993
47. Sano T, Kawamura T, Matsumae H, Sasaki H, Nakayama M, Hara T, Matsuo S, Hotta N, Sakamota N: Effects of long-term enalapril treatment on persistent microalbuminuria in well-controlled hypertensive and normotensive NIDDM patients Diabetes Care 17:420-424, 1994
48. Mykkänen L, Haffner SM, Kuusisto J, Pyörälä K, Laakso M: Microalbuminuria precedes the development of NIDDM. Diabetes 43:552-557, 1994
49. Moorhead JF, El Nahas M, Chan MK, Varghese Z: Lipid nephrotoxicity in chronic progressive glomerular and tubule-interstitial disease. Lancet ii:1309-1312, 1988
50. Borch-Johnsen K, Kreiner S. Proteinuria. a predictor of cardiovascular mortality in insulin-dependent diabetes mellitus. Br Med J 294:1651-1654, 1987
51. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A: Albuminuria reflects widespread vascular damage the Steno hypothesis. Diabetologia 32:219-226, 1989
52. Haffner SM, Stern MP, Gruber MK, Hazuda HP, Mitchell BD, Pattersson JK: Microalbuminuria: potential marker for increased cardiovascular risk factors in nondiabetic subjects? Arteriosclerosis 10: 727-731, 1990